With no cure in sight, drugs firm LianBio begins exit strategy
The biotech, which obtained rights to novel drugs for use in the Chinese market, has announced a plan to wind up its business and delist from the Nasdaq just four…
Former aluminum highflyer Zhongwang headed for listed company scrapheap
The company will be booted from the Hong Kong Stock Exchange on Thursday after failing to provide any financials since its 2020 annual report Key Takeaways: Zhongwang will be de-listed…
Tuya Seeks Hong Kong IPO to Hedge U.S. Delisting Risk, But Investors Are Wary
With the possibility of being forced to delist from the U.S. market by the SEC, Tuya is primarily seeking a safe harbor and only aims to raise a conservative HK$140…
Investors Unfazed as TAL Education Added to List of Chinese Firms at Risk of Delisting
The education company’s shares fell 1.6% after it was cited by the U.S. securities regulator for non-compliance with the Holding Foreign Companies Accountable Act Key Takeaways: The U.S. Securities and…
FAST NEWS: Hutchmed Receives Additional Holdings from U.S. Fund
The latest: The Capital Group Companies, Inc., a U.S.-based fund disclosed it purchased 1.285 million shares in Hutchmed (China) Ltd. (HCM.US; 0013.HK) for HK$22.14 million ($2.84 million), raising its stake…
FAST NEWS: Luckin Coffee Denies Hong Kong Listing Plan
The latest: Chinese coffee chain Luckin Coffee Inc. (LKNCY.US) said in a statement Monday that it is not seeking a Hong Kong listing at this time, refuting a media report…
FAST NEWS: Qudian Regains Compliance With New York Listing Rules
The latest: Online lender Qudian Inc. (QD.US) said on Thursday it has regained compliance with New York Stock Exchange listing rules, after its average closing price for the last 30…
Recent Articles
RELATED ARTICLES
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US -
Kintor shares plunge after hair-loss drug flops in clinical trials
9939.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
- InSilico seeks IPO boost to get AI drugs over the line
-
Adlai Nortye dives in Nasdaq debut, as key product faces hurdles
ANL.US
-
Drug maker Junshi seeks Swiss cure for cash woes
1877.HK 688150.SHG
